Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University of Chicago
Wake Forest University Health Sciences
VLP Therapeutics
Memorial Sloan Kettering Cancer Center
Alpha Tau Medical LTD.
University of Chicago
M.D. Anderson Cancer Center
University of Pittsburgh
Bicara Therapeutics
UNICANCER